(Q47245565)

12 January 2018

title

Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation (English)

1 reference

12 January 2018

author

Elisabetta Padovan

5

1 reference

12 January 2018

Paul Zajac

6

1 reference

12 January 2018

Michel Adamina

2

object named as

Michel Adamina

1 reference

12 January 2018

Reto Schumacher

1

1 reference

12 January 2018

Rinaldo Zurbriggen

3

1 reference

12 January 2018

Martin Bolli

4

1 reference

12 January 2018

Michael Heberer

7

1 reference

12 January 2018

Giulio C Spagnoli

8

1 reference

12 January 2018

language of work or name

English

0 references

publication date

1 January 2004

1 reference

12 January 2018

published in

Vaccine

1 reference

12 January 2018

volume

22

1 reference

12 January 2018

issue

5-6

1 reference

12 January 2018

page(s)

714-723

1 reference

12 January 2018

Advances in vaccine adjuvants

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

Fully mobilizing host defense: building better vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

Vaccines against intracellular infections requiring cellular immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

Towards the rational design of Th1 adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

Immunogenicity of new virosome influenza vaccine in elderly people

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

Novel approaches in the development of immunopotentiating reconstituted influenza virosomes as efficient antigen carrier systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

Class I-restricted presentation of exogenous antigen acquired by Fcγ receptor-mediated endocytosis is regulated in dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

An immunoenzymatic method for measuring low concentrations of antigens by single radial diffusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

Differential effects of interleukin-2 and CD3 triggering on cytokine gene transcription and secretion in cultured tumor infiltrating lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

Mature dendritic cells prime functionally superior melan-A-specific CD8+ lymphocytes as compared with nonprofessional APC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

Adjuvant activity of immunopotentiating reconstituted influenza virosomes (IRIVs)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

Immunology. Licence to kill.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

Induction of a cytotoxic T lymphocyte (CTL) response to plasmid DNA delivered via Lipodine liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

A role for liposomes in genetic vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

The polypeptide composition of influenza A viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.019

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2003.08.019

1 reference

12 January 2018

PubMed ID

14741164

1 reference

12 January 2018